825 Eastlake Avenue East, Seattle, WA, 98109 · (206) 667-5000
Beds
20
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$1.61B
FY 2025
Net income
$119.4M
Patient care margin -50.4%
Discharges
481
Occupancy 90.3%
Clinicians
933
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1.61B | $2.43B | -50.4% | $119.4M | 481 | - | 27.1% | 1.5% |
Medicare clinicians who list this hospital, by specialty
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 628 | 493 | $2,300.92 | $2,141.49 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 540 | 415 | $1,313.97 | $1,219.56 |
| APC 5183 Level 3 Vascular Procedures |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $1.30B | $2.10B | -61.5% | -$38.0M | 532 | - | 22.0% | 4.9% |
| 2023 | $1.17B | $1.98B | -68.6% | $369.4M | 529 | - | 22.4% | 3.0% |
| 2022 | $1.01B | $1.05B | -3.6% | -$38.2M | 522 | - | 24.4% | 4.0% |
| 2021 | $890.3M | $840.8M | 5.5% | $151.3M | 581 | - | 21.0% | 2.5% |
| 2020 | $753.0M | $734.9M | 2.4% | $69.5M | 469 | - | 20.0% | 3.2% |
| 261 |
| 252 |
| $2,583.31 |
| $2,405.01 |
| APC 5182 Level 2 Vascular Procedures | 77 | 77 | $1,302.02 | $1,204.32 |
| APC 5302 Level 2 Upper GI Procedures | 64 | 60 | $1,472.77 | $1,444.50 |
| APC 5375 Level 5 Urology and Related Services | 20 | 17 | $3,789.24 | $3,917.51 |
| APC 5153 Level 3 Airway Endoscopy | 14 | 13 | $1,282.39 | $1,264.08 |
| APC 5154 Level 4 Airway Endoscopy | 12 | 12 | $3,047.10 | $2,832.62 |
| APC 5244 Level 4 Blood Product Exchange and Related Services | - | - | - | $56,849.60 |
| APC 5184 Level 4 Vascular Procedures | - | - | - | $3,945.82 |
| APC 5303 Level 3 Upper GI Procedures | - | - | - | $2,887.88 |
| APC 5313 Level 3 Lower GI Procedures | - | - | - | $2,176.09 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Fred Hutchinson Cancer Center is a nonprofit short-term acute care hospital in Seattle, WA with 20 beds.
Fred Hutchinson Cancer Center in Seattle, WA has 20 beds (fiscal year 2025 cost report). It discharged 481 inpatients that year, with 90.3% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Fred Hutchinson Cancer Center reported net patient revenue of $1.61B and operating expenses of $2.43B, a margin on patient care of -50.4%. After other income and expenses its net income was $119.4M (4.6% of revenue), so it made a profit that year.
Fred Hutchinson Cancer Center is not part of a multi-hospital health system in the official ownership records. It is a nonprofit hospital (Nonprofit (other)).
Fred Hutchinson Cancer Center has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Emergency services are not reported for Fred Hutchinson Cancer Center.
933 Medicare clinicians list Fred Hutchinson Cancer Center as a hospital they work at, most often in Nurse Practitioner, Physician Assistant, Hematology/Oncology.